WEB Magazine "Kosei Rodo" | Medical Institution M&A Support

SUMMARY

According to news reports of press releases from the Ministry of Health, Labour and Welfare, "WEB Magazine "Kosei Rodo"" has been reported. This information serves as a reference for management decisions concerning hospitals, clinics, and medical corporations, reflecting the latest trends in the healthcare industry.

📝 EDITOR'S NOTE — A Medical M&A Perspective

Trends in the medical industry directly impact the succession and M&A strategies of hospitals, clinics, and medical corporations. Changes in the complex management environment, such as revisions to medical fees, lack of successors, staffing shortages, burden of capital investment, and progress in regional medical plans, are forcing medical institutions to make new management decisions.

As an option for successor issues and changes in the management environment,Third-Party Succession M&Ais increasing in importance year by year. Choosing succession over closure or廃業 (business dissolution) allows for the simultaneous achievement of securing a transfer price, maintaining staff employment, ensuring continuity of patient care, and preserving regional medical services. The framework of M&A support institutions certified by the Small and Medium Enterprise Agency has also been established, and advisory services specializing in the unique licensing, tax, and labor issues of the medical industry have become widespread.

For medical institutions, accurately grasping industry trends and seeking early consultation with experts are key to attracting the best options for management decisions. As an M&A advisory firm specializing in the medical industry, we support medical institutions with free consultations and success-fee-based services.

News Highlights

The WEB magazine “Kosei Rodo” presents third-party succession as an alternative to closure or廃業 (haigyo – business cessation) to address the issue of successors in medical institutions. It emphasizes the importance of early consideration in 5-10 year increments starting around age 60 for chairpersons and directors, and recommends utilizing specialized advisors focused on the medical industry.

M&A Medical Editorial Department’s Perspective

The tone of “Kosei Rodo” magazine recommending third-party succession for successor issues can be seen as a reflection of the quiet sense of crisis among medical institution managers. In particular, mentioning the specific age of around 60 for chairpersons and directors, and urging preparation over a 5-10 year span, moves beyond abstract theory to demand concrete action plans. This is a realistic step that M&A Medical (CentralMedience Inc.) experiences daily to avoid closures and business cessation due to lack of successors and to preserve the light of regional healthcare. The lack of successors is an urgent issue directly related to the survival of medical institutions, and early consultation with experts is the first step towards building the optimal succession scheme.

Points Raised by This News

Lack of successors poses a risk of closure or business cessation, with third-party succession serving as a realistic solution.
Preparation for business succession over a 5-10 year period, starting around age 60, is recommended.
Utilizing advisors specialized in the medical industry is key to smooth succession.
From the perspective of maintaining regional healthcare, third-party succession is an important option.

Practical Questions Arising from This News

What specific third-party succession schemes can be considered?
When is the optimal time to consult with a specialized advisor?
How will the impact on employees and patients be considered during succession?

If You Feel “Should I Consult?”

If your institution’s chairperson or director is approaching age 60 and the situation of lacking a successor continues, it is a sign that you should consider third-party succession, which allows for the continuation of business while protecting regional healthcare, as an alternative to closure or business cessation. In particular, by looking ahead to business succession in 5-10 years and consulting with experts in medical M&A early on, it becomes possible to build an optimal succession scheme that leverages your institution’s strengths.

M&A Medical (CentralMedience Inc.) is an M&A support institution certified by the Small and Medium Enterprise Agency, supporting the business succession of medical corporations, hospitals, and clinics on a full success fee basis. Consultations are accepted with strict confidentiality. Free consultation here

📌 Source (Primary Information)

WEB Magazine “Kosei Rodo”

Source: Ministry of Health, Labour and Welfare Press Releases

Please see the original article for details

Regarding trends in medical institutions like this case,

we provide a detailed explanation of the 'Medical Succession Guide'

Read the Complete Guide →